S&P 500   4,633.16 (+1.45%)
DOW   34,831.46 (+1.01%)
QQQ   398.21 (+1.11%)
AAPL   169.85 (+2.75%)
MSFT   337.98 (+2.24%)
FB   319.37 (-1.57%)
GOOGL   2,892.54 (+1.92%)
AMZN   3,527.40 (+0.58%)
TSLA   1,152.75 (+0.70%)
NVDA   328.23 (+0.45%)
BABA   125.66 (-1.47%)
NIO   40.11 (+2.50%)
CGC   10.46 (-2.33%)
AMD   157.11 (-0.80%)
GE   95.94 (+1.00%)
MU   88.65 (+5.54%)
T   22.64 (-0.83%)
F   20.23 (+5.42%)
DIS   145.63 (+0.50%)
PFE   54.60 (+1.62%)
ACB   6.31 (-1.71%)
AMC   33.50 (-1.30%)
BA   196.35 (-0.76%)
S&P 500   4,633.16 (+1.45%)
DOW   34,831.46 (+1.01%)
QQQ   398.21 (+1.11%)
AAPL   169.85 (+2.75%)
MSFT   337.98 (+2.24%)
FB   319.37 (-1.57%)
GOOGL   2,892.54 (+1.92%)
AMZN   3,527.40 (+0.58%)
TSLA   1,152.75 (+0.70%)
NVDA   328.23 (+0.45%)
BABA   125.66 (-1.47%)
NIO   40.11 (+2.50%)
CGC   10.46 (-2.33%)
AMD   157.11 (-0.80%)
GE   95.94 (+1.00%)
MU   88.65 (+5.54%)
T   22.64 (-0.83%)
F   20.23 (+5.42%)
DIS   145.63 (+0.50%)
PFE   54.60 (+1.62%)
ACB   6.31 (-1.71%)
AMC   33.50 (-1.30%)
BA   196.35 (-0.76%)
S&P 500   4,633.16 (+1.45%)
DOW   34,831.46 (+1.01%)
QQQ   398.21 (+1.11%)
AAPL   169.85 (+2.75%)
MSFT   337.98 (+2.24%)
FB   319.37 (-1.57%)
GOOGL   2,892.54 (+1.92%)
AMZN   3,527.40 (+0.58%)
TSLA   1,152.75 (+0.70%)
NVDA   328.23 (+0.45%)
BABA   125.66 (-1.47%)
NIO   40.11 (+2.50%)
CGC   10.46 (-2.33%)
AMD   157.11 (-0.80%)
GE   95.94 (+1.00%)
MU   88.65 (+5.54%)
T   22.64 (-0.83%)
F   20.23 (+5.42%)
DIS   145.63 (+0.50%)
PFE   54.60 (+1.62%)
ACB   6.31 (-1.71%)
AMC   33.50 (-1.30%)
BA   196.35 (-0.76%)
S&P 500   4,633.16 (+1.45%)
DOW   34,831.46 (+1.01%)
QQQ   398.21 (+1.11%)
AAPL   169.85 (+2.75%)
MSFT   337.98 (+2.24%)
FB   319.37 (-1.57%)
GOOGL   2,892.54 (+1.92%)
AMZN   3,527.40 (+0.58%)
TSLA   1,152.75 (+0.70%)
NVDA   328.23 (+0.45%)
BABA   125.66 (-1.47%)
NIO   40.11 (+2.50%)
CGC   10.46 (-2.33%)
AMD   157.11 (-0.80%)
GE   95.94 (+1.00%)
MU   88.65 (+5.54%)
T   22.64 (-0.83%)
F   20.23 (+5.42%)
DIS   145.63 (+0.50%)
PFE   54.60 (+1.62%)
ACB   6.31 (-1.71%)
AMC   33.50 (-1.30%)
BA   196.35 (-0.76%)
NASDAQ:LNSR

LENSAR Stock Forecast, Price & News

$6.75
-0.07 (-1.03%)
(As of 12/1/2021 11:31 AM ET)
Add
Compare
Today's Range
$6.75
$6.89
50-Day Range
$6.82
$8.13
52-Week Range
$6.13
$9.83
Volume
82 shs
Average Volume
29,758 shs
Market Capitalization
$73.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive LNSR News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.


LENSAR logo

About LENSAR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LNSR
Fax
N/A
Employees
35
Year Founded
N/A

Sales & Book Value

Annual Sales
$26.38 million
Book Value
$6.32 per share

Profitability

Net Income
$-19.77 million
Pretax Margin
-71.47%

Debt

Price-To-Earnings

Miscellaneous

Free Float
9,061,000
Market Cap
$73.96 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/08/2021
Today
12/01/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
3/09/2022

MarketRank

Overall MarketRank

2.04 out of 5 stars

Medical Sector

549th out of 1,390 stocks

Surgical & Medical Instruments Industry

58th out of 127 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












LENSAR (NASDAQ:LNSR) Frequently Asked Questions

Is LENSAR a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LENSAR in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LENSAR stock.
View analyst ratings for LENSAR
or view top-rated stocks.

When is LENSAR's next earnings date?

LENSAR is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for LENSAR
.

How were LENSAR's earnings last quarter?

LENSAR, Inc. (NASDAQ:LNSR) released its quarterly earnings results on Monday, November, 8th. The company reported ($0.65) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.06. The business had revenue of $8.27 million for the quarter, compared to analyst estimates of $7.67 million. LENSAR had a negative net margin of 71.47% and a negative trailing twelve-month return on equity of 36.01%. During the same period in the prior year, the company posted ($0.64) earnings per share.
View LENSAR's earnings history
.

What price target have analysts set for LNSR?

2 equities research analysts have issued twelve-month price objectives for LENSAR's shares. Their forecasts range from $15.00 to $20.00. On average, they expect LENSAR's stock price to reach $17.50 in the next twelve months. This suggests a possible upside of 159.3% from the stock's current price.
View analysts' price targets for LENSAR
or view top-rated stocks among Wall Street analysts.

Who are LENSAR's key executives?

LENSAR's management team includes the following people:
  • Mr. Nicholas T. Curtis, CEO & Director (Age 65, Pay $748.46k)
  • Mr. Thomas R. Staab II, Chief Financial Officer (Age 53, Pay $347.26k)
  • Mr. Alan B. Connaughton, Chief Operating Officer (Age 49, Pay $519.52k)

What is LENSAR's stock symbol?

LENSAR trades on the NASDAQ under the ticker symbol "LNSR."

Who are LENSAR's major shareholders?

LENSAR's stock is owned by a number of retail and institutional investors. Top institutional investors include Park West Asset Management LLC (9.59%), Dimensional Fund Advisors LP (6.22%), Madison Avenue Partners LP (6.17%), Renaissance Technologies LLC (3.38%), BlackRock Inc. (1.64%) and Millennium Management LLC (0.99%).

Which institutional investors are buying LENSAR stock?

LNSR stock was acquired by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, Dimensional Fund Advisors LP, Madison Avenue Partners LP, Renaissance Technologies LLC, BlackRock Inc., Millennium Management LLC, Connor Clark & Lunn Investment Management Ltd., and Geode Capital Management LLC.

How do I buy shares of LENSAR?

Shares of LNSR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LENSAR's stock price today?

One share of LNSR stock can currently be purchased for approximately $6.75.

How much money does LENSAR make?

LENSAR has a market capitalization of $73.96 million and generates $26.38 million in revenue each year. The company earns $-19.77 million in net income (profit) each year or ($2.46) on an earnings per share basis.

How many employees does LENSAR have?

LENSAR employs 35 workers across the globe.

What is LENSAR's official website?

The official website for LENSAR is www.lensar.com.

How can I contact LENSAR?

The company can be reached via phone at 888-536-7271 or via email at [email protected].


This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.